Biotechnology Get all the latest news from the field of biotechnology including testing, treatment, and pharmaceuticals. This category includes research, clinical, and study results, as well as stories about the newest breakthroughs in the industry. Read stories about upcoming conferences and symposiums, along with releases regarding patents, legal activity, company performance and market analysis.

Latest

13:31 BST Crown Laboratories Acquires Xycrobe™ Therapeutics, Inc., an Innovator in Skin Microbiome Technology

Crown Laboratories, Inc. ("Crown"), a leading, fully integrated skin care company, today announced it has acquired Xycrobe Therapeutics, Inc....


13:30 BST Digital PCR (dPCR) and Real-time PCR (qPCR) Market Worth $6.3 Billion by 2024 - Exclusive Report by MarketsandMarkets™

According to the new market research report "Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software,...


13:00 BST EpiBone, Inc. Receives FDA Clearance to Commence its First-In-Human, Phase 1/2 Trial of its Bone Product, EB-CMF

EpiBone, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed...


12:00 BST Alkermes to Present New Data From Mental Health Portfolio at the American Society of Clinical Psychopharmacology 2019 Annual Meeting

Alkermes plc (Nasdaq: ALKS) today announced plans to present new data from its mental health portfolio at the American Society of Clinical...


07:45 BST BioInvent Interim Report January 1 - March 31, 2019

Net sales SEK 17.4 (11.3) million Earnings after tax SEK -27.8 (-24.9) million Earnings after tax per share before and after dilution: SEK -0.08...


07:40 BST Amgen announces a recommended public cash offer to the shareholders of Nuevolution

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be...


21 May, 2019, 09:00 BST EPO Revokes Regenlab PRP Patent

Estar Medical has been successful in revoking Regenlab's original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling...


21 May, 2019, 08:00 BST Debiopharm Expands Its Immuno-oncology Development Program for Debio 1143, With the First IAP Inhibitor/Nivolumab Combination Trial

Debiopharm (www.debiopharm.com) announced today the first patient enrolled in SMARTPLUS-106, an exploratory study investigating the safety and...


21 May, 2019, 07:23 BST Oncopeptides AB: INTERIM REPORT Q1 2019

"The initiation of the filing process for melflufen in the US is a major milestone for Oncopeptides." Financial overview January 1 – March 31, 2019...


20 May, 2019, 14:35 BST Biotech Brief: Electrophysiology Devices Billion Dollar Market Growth Made Possible by Innovative Technologies

The Electrophysiology marketplace is: "set for explosive growth" says an industry publication. It stated: "In the world of cardiovascular devices,...


20 May, 2019, 13:30 BST Veterinary Rapid Test Market Worth $854 Million by 2024 - Exclusive Report by MarketsandMarkets™

According to the new market research report "Veterinary Rapid Test Market by Product (Rapid Test Kit, Rapid Test Readers), Application (Viral,...


20 May, 2019, 09:00 BST Asceneuron Appoints Experienced CNS Clinician Dr Eric Yuen to the Board of Directors

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today...


20 May, 2019, 07:00 BST Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss

Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, announced today that it successfully secured £1....


17 May, 2019, 13:00 BST Therachon to Present Data from Ongoing Phase II Study of Apraglutide for Short Bowel Syndrome (SBS) at Digestive Disease Week

Therachon AG ("Therachon"), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative...


17 May, 2019, 00:00 BST InnoVEX Returns in 2019 for New Thinking, New Engineering, and New Future

InnoVEX is the startup focused special exhibition of COMPUTEX. Started in 2016, the event has continued to see significant growth every year. InnoVEX ...


16 May, 2019, 21:30 BST Jazz Pharmaceuticals to Present New Data at Upcoming ASCO Annual Meeting and EHA Congress

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that it will present data from across its hematology/oncology portfolio and pipeline at the...


16 May, 2019, 14:18 BST Oncopeptides Announces Acceptance of Four Abstracts Highlighting Melflufen Clinical Programs for Presentation at 24th EHA Congress in June 2019

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that a total of four abstracts have been accepted for presentation at the 24th Congress of...


16 May, 2019, 07:00 BST 4D Presents Phase Ib Clinical Data on Thetanix®

4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of Live Biotherapeutics, today announced that data from the completed ...


16 May, 2019, 06:00 BST Pharming Group Reports Interim Financial Results for the First Quarter of 2019

Main results compared to Q1 2018 19.5% increase in revenues 49% increase in operating profit 23% increase in net profit Pharming Group N.V....


16 May, 2019, 00:29 BST Alligator Bioscience: ADC-1013 Clinical Phase I Data to be Presented at ASCO

Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that Janssen Biotech, Inc. (Janssen) will present data from a Phase I clinical study...


16 May, 2019, 00:10 BST Oncopeptides Announces Melflufen Data Accepted for Presentation at 2019 ASCO Annual Meeting

Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that data from its Phase 1/2 O-12-M1 study evaluating melflufen, a lipophilic...


15 May, 2019, 23:35 BST BerGenBio to Present New NSCLC and AML Clinical Data and Biomarker Data From Phase II Development Programme With Selective AXL Inhibitor Bemcentinib at ASCO 2019

Two peer reviewed abstracts on Phase II clinical data with bemcentinib accepted for presentation at ASCO 2019 Non-Small-Cell Lung Cancer (NSCLC)...


15 May, 2019, 13:53 BST Hangzhou attracts RMB1.5 billion investments in bio-pharmaceutical projects in Q1

Hangzhou, capital of east China's Zhejiang Province, has seen seven bio-pharmaceutical projects implemented in the first quarter of the year, with a...


15 May, 2019, 13:00 BST IO Biotech Initiates Global Phase 2 Portion of Clinical Trial For T-win® Immunotherapy in Non-small Cell Lung Cancer

IO Biotech, a clinical-stage biopharmaceutical company developing novel, immune modulating anti-cancer therapies based on its proprietary T-win®...


15 May, 2019, 12:41 BST Pharmacogenomics Market Soaring at 8.61% CAGR to Surpass 10,265 Million by 2025

The global pharmacogenomics market generated $5,312.8 million in 2017 and is projected to reach $10,265.5 million by 2025, growing at a CAGR of 8.61% ...